NEW YORK, August 6, 2008 – Researchers at the NYU Cancer Institute and the Ronald O. Perelman Department of Dermatology have identified mebendazole, a drug used globally to treat parasitic infections, ...
Multi-institutional randomized phase 3 trial comparing cancer stem cell-targeted versus physician-choice treatments in patients with recurrent high-grade gliomas (NCT03632135). This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results